Goal Attainment Scale for Depression 日本語版
Goal Attainment Scale for Depression 日本語版
GAS-D日本語版 Sample版
GAS-D
©2017 Takeda Pharmaceuticals U.S.A., Inc. All rights reserved.
GAS-D日本語版
Takeda Pharmaceuticals U.S.A., Inc の許諾のもと、ルンドベック‧ジャパン株式会社によって日本語に翻訳のうえ作製された。
無断で転載‧複写‧複製‧改変することを禁じます。
※本ページにて表示されるGAS-D日本語版は閲覧用のサンプルであり、全文ではなく、一部のみ表示しています。
参考⽂献
1. Sagar V. Parikh, Maggie McCue, Lisa Mucha, Sara Sarkey, Jennifer Schuster, Anna Eramo,Clement François, May 2017. A Novel Use of the Goal Attainment Scale After Change to Vortioxetine in the Treatment of Major Depressive Disorder. Presented at the American Society of Clinical Psychopharmacology, Miami, Florida.
2. McCue M, Parikh SV, Mucha L, et al. 2018. Personalized goal attainment after a switch to vortioxetine in adults with major depressive disorder (MDD): results of a phase 4, open-label clinical trial’, Presented at US Psychiatric and Mental Health Congress. Orlando, FL.
3. McCue M, Parikh SV, Mucha L, Sarkey S, Cao C, Eramo A, Opler M, Webber-Lind B, Francois C: Adapting the Goal Attainment Approach for Major Depressive Disorder. Neurol Ther 2019,8(2):167-176.
4. McCue M, Sarkey S, Eramo A, Francois C, Parikh SV: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase , single-arm, open-label, multicenter study. BMC Psychiatry 2021,21(1):622 .
5. Kato M, Kikuchi T, Watanabe K, Sumiyoshi T, Moriguchi Y, Oudin Astrom D, Christensen MC: Goal Attainment Scaling for Depression: Validation of the Japanese GAS-D Tool in Patients with Major Depressive Disorder. Neuropsychiatr Dis Treat 2024,20:49-60.